by Dr. Aung Myo | 29/11/2024 | Uncategorised
Allogeneic CAR-T or T Cell Therapy By Dr. Aung Myo, Founder & Principal Consultant, Innovicto 29, November,2024 In our previous article, we delved into the challenges faced by autologous CAR-T therapies—challenges that are applicable to all CAR-T and T cell...
by Dr. Aung Myo | 02/11/2024 | Uncategorised
By Dr. Aung Myo, Founder & Principal Consultant, Innovicto 2nd November,2024 T cell therapy has revolutionized anti-cancer treatment, with the U.S. FDA approving six autologous CAR-T cell therapies and recently in 2024...
